Preferred Sample Type

ADAMTS13 Activity / Inhibitor (IgG)

ADAMTS13 Activity / Inhibitor (IgG)

Specimen Volume

3 x 3.5 mL (Vacuette tubes) or 2.7mL (BD Vacutainer tubes)

Specimen Transport

Standard transport to laboratory - State for the attention of Special Coagulation on request form

Sample Preparation

Samples must be filled to the black fill line (Vacuette tubes) or the frosted line (BD Vacutainer tubes) indicated on the sample tube. Any sample filled above or below this level will be rejected and a repeat sample will be required

Turnaround Time

ADAMTS13 Activity: 6 hours for urgent requests, 7 days for routine requests, ADAMTS13 Inhibitor: 21 days.

Sample Processing In Laboratory

Sample should be centrifuged

Sample Stability

Up to 72 hours from venepuncture

General Information

Note: If you suspect MAHA/TTP, please contact the UHB Haematology Consultant via Switchboard for urgent advice. Tel: 0121 627 200.

For urgent samples, Tel: 0121 371 5988 (Special Coagulation Lab at QE) or 0121 371 6920 out of hours. Samples can be sent for processing 24 hours a day.

External Requests:

For external requests please click Here for ADAMTS13 request form. Please complete all information fully

Sample packing and transportation:

Frozen plasma should be sent on dry ice using an insulated container to ensure that it remains frozen during transport. Please refer to the preanalytical variables section of the BSH guidelines on the laboratory aspects of assays used in haemostasis and thrombosis1.

As an alternative the bio-freeze container system can be used to ensure samples remain frozen in transit. These have been locally validated to maintain samples at -20oC for up to 12 hours  providing they have been preconditioned in a -80oC freezer for 24 hours prior to use.

Disclaimer:

Please note failure to use an appropriate transit container may affect sample integrity, thus the accuracy of results cannot be guaranteed.  Furthermore, samples packaged incorrectly that arrive in a thawed state cannot be tested.

Please contact the laboratory on 0121 371 5988 (Queen Elizabeth Hospital) if you require any further information.

1) Baker, P., Platton, S., Gibson, C., Gray, E., Jennings, I., Murphy, P., Laffan, M. and British Society for Haematology, Haemostasis and Thrombosis Task Force (2020), Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Br. J. Haematol., 191: 347-362.

https://doi.org/10.1111/bjh.16776

Samples that meet the following criteria will not be processed:

  • Haemolysed, clotted, underfilled or overfilled samples.
  • Samples >12 hours old from the time of collection.
  • Samples received from other hospital laboratories that have been frozen and thawed.
  • Samples which fail the minimum data set.

Assay limitations:

  • Samples containing EDTA cannot be used because EDTA is a strong inhibitor of ADAMTS13 function

Underfilled samples for ADAMTS13 Activity only:

  • Underfilled samples CAN be accepted for ADAMTS13 Activity only providing the sample tube is at least half full.

Reference Range

Reference Ranges are dependent upon methodology:

ADAMTS13 Activity:

ACUSTAR (primary method): 62-118 IU/dL

ELISA (secondary method, used for confirmatory check of equivocal results): 38-110%

ADAMTS13 inhibitor (IgG):

Neg <12 U/mL

Borderline 12-15 U/mL

Positive >15 U/mL

Specifications

  • EQA Status: ECAT / NEQAS
  • EQAS Scheme: Yes

General Information

General information about the website and its content

Location of Laboratories

Where the laboratories are located and information about the services offered at each laboratory